Literature DB >> 23315720

Technical preferences of surgeons performing a sacrocolpopexy procedure.

Renee Bassaly1, Mona McCullough, Deana Hussamy, Katheryne Downes, Lennox Hoyte, Stuart Hart.   

Abstract

The purpose of this study is to report on the surgical preferences of international surgeons in the performance of the sacrocolpopexy procedure. Invitations to complete this Internet-based survey were sent to 2,854 International Urogynecological Association (IUGA) members from December 2010 through February 2011. Questions were related to various aspects of the surgeons' techniques and preferences in the performance of a sacrocolpopexy procedure by the abdominal, laparoscopic, and robotic routes. Descriptive statistics are reported. A total of 235 members from six continents completed the survey. Ninety percent of the respondents perform sacrocolpopexy procedures in their practices, including abdominal (n = 177), laparoscopic (n = 92), and robotic (n = 48) procedures. Participants reported reduced blood loss, shorter hospitalization, and longer operative time during laparoscopic and robotic procedures compared with open abdominal sacrocolpopexy, but no differences were reported in overall major complications. Overall, surgical preferences and techniques of international surgeons for sacrocolpopexy were similar among responders, regardless of the surgical route performed.

Entities:  

Mesh:

Year:  2012        PMID: 23315720

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  3 in total

Review 1.  Robotic pelvic organ prolapse surgery.

Authors:  Kamran P Sajadi; Howard B Goldman
Journal:  Nat Rev Urol       Date:  2015-03-24       Impact factor: 14.432

2.  Clinical outcome of abdominal sacrocolpopexy.

Authors:  Shikha Rani; Dilpreet Kaur Pandher; Anju Huria; Reeti Mehra
Journal:  J Midlife Health       Date:  2015 Oct-Dec

3.  Gynaecologists' views on the management of Vaginal Vault Prolapse: A qualitative study.

Authors:  Omaema Al-Baghdadi; Christian Barnick; Garima Srivastava; Hassan M Elbiss
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.